Osaic Holdings
ORKA

Osaic Holdings’s Oruka Therapeutics ORKA Stock Holding History

Osaic Holdings’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Buy
813
+716
+738% +$47.7K ﹤0.01% 5145
2026
Q1 		$4.76K Buy
97
+93
+2,325% +$3.23K ﹤0.01% 6709
2025
Q4 		$121 Buy
4
+3
+300% +$84 ﹤0.01% 7631
2025
Q3 		$19 Hold
1
– – ﹤0.01% 7833
2025
Q2 		$11 Buy
+1
New +$10 ﹤0.01% 7687
2024
Q1 		– Sell
-5
Closed -$93 – 7431
2023
Q4 		$93 Hold
5
– – ﹤0.01% 7116
2023
Q3 		$110 Hold
5
– – ﹤0.01% 7217
2023
Q2 		$115 Hold
5
– – ﹤0.01% 7270
2023
Q1 		$113 Hold
5
– – ﹤0.01% 7321
2022
Q4 		$0 Hold
5
– – ﹤0.01% 7466
2022
Q3 		$0 Hold
5
– – ﹤0.01% 7555
2022
Q2 		$0 Hold
5
– – ﹤0.01% 7647
2022
Q1 		$0 Sell
5
-4
-44% -$99 ﹤0.01% 7552
2021
Q4 		$0 Hold
9
– – ﹤0.01% 7616
2021
Q3 		$0 Sell
9
-4
-31% -$148 ﹤0.01% 7346
2021
Q2 		$0 Hold
13
– – ﹤0.01% 7156
2021
Q1 		$0 Hold
13
– – ﹤0.01% 6973
2020
Q4 		$0 Hold
13
– – ﹤0.01% 6611
2020
Q3 		$0 Buy
13
+8
+160% +$564 ﹤0.01% 6447
2020
Q2 		$0 Hold
5
– – ﹤0.01% 6374
2020
Q1 		$0 Buy
+5
New +$272 ﹤0.01% 6212

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Osaic Holdings's ORKA Position: Q2 2026 in Review

Osaic Holdings increased its Oruka Therapeutics (ORKA) stake by 738% in Q2 2026, buying an estimated $47.7K and bringing the position to 813 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5145.

Osaic Holdings first reported a position in ORKA in Q1 2020 and has held it in 21 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Osaic Holdings held 813 shares of Oruka Therapeutics worth $77.4K as of Q2 2026.
  • Osaic Holdings bought 716 Oruka Therapeutics shares in Q2 2026, an estimated $47.7K.
  • Oruka Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5145 holding.
  • Osaic Holdings first reported a position in Oruka Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.